Delivery Order SPE2DE21D7020-SPE2D626F1634
- Not listed
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $6,652.60 for enroute TCAR stents on September 26, 2025, with an ultimate completion date of October 3, 2025. This fixed-price contract with economic price adjustment was issued by the Defense Health Agency's Medical Supply Chain division and will be performed in Marlborough, MA. The contract represents no set-aside designation, allowing Boston...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $7,593.10 for EnRoute TCAR stents on August 14, 2025. This fixed-price contract with economic price adjustment is scheduled for ultimate completion by August 21, 2025, and will be performed at Boston Scientific's Marlborough facility. The award is being funded through the Defense Health Agency's Medical Supply Chain, a defense-focused federal...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 4, awarded a delivery order valued at $52,168.93 to Boston Scientific Corp for an Emergency Enroute Transcarotid Neuroprotection System. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating open competition. Performance will occur in Pittsburgh, Pennsylvania, with a completion date of December 31, 2028. Boston Scientific, a global medical technology company...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $2,157.35 by the Defense Health Agency's Medical Supply Chain on August 19, 2025. The contract covers a Selective MC Single Bern 130CM medical device and carries an ultimate completion date of August 26, 2025. This fixed-price delivery order with economic price adjustment represents one of numerous federal contract awards Boston Scientific...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a fixed-price delivery order valued at $12,317.30 by the Defense Health Agency's Medical Supply Chain division. The delivery order, designated as a non-set-aside contract with an ultimate completion date of August 27, 2025, represents a continuation of Boston Scientific's role as a critical supplier of advanced medical devices to federal healthcare agencies. The contract is...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $18,343.80 by the Defense Health Agency's Medical Supply Chain on May 1, 2025. This fixed-price contract with economic price adjustment provisions is scheduled for completion by May 8, 2025, and represents the company's continued supply of specialized medical devices to the Department of Defense healthcare system. The award was not set aside for any...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $6,118.95 by the Defense Health Agency's Medical Supply Chain on September 16, 2025. This fixed-price contract with economic price adjustment provisions has an ultimate completion date of September 23, 2025 and carries no set-aside designation, indicating open competition in the federal marketplace. The work will be performed at Boston Scientific's...
- Boston Scientific Corp, a global medical technology company based in Marlborough, Massachusetts, has been awarded a $237,249.79 fixed-price delivery order with economic price adjustment by the Defense Health Agency's Medical Supply Chain on August 25, 2025. This delivery order, with an ultimate completion date of September 2, 2025, represents a component of Boston Scientific's broader federal contracting relationship with the Department of Defense healthcare system. The award carries no...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $26,333.86 under the Defense Health Agency's Medical Supply Chain program. The contract, designated as ENROUTE NPS PLUS (Contract Number 4569108655), is structured as a fixed-price delivery order with economic price adjustment provisions and carries an ultimate completion date of August 22, 2025. As a non-set-aside award, Boston Scientific...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a $3,201.54 fixed-price delivery order (Contract No. 4568919661, designated INTERLOCK 35) by the Defense Health Agency's Medical Supply Chain program. The delivery order, effective through August 5, 2025, represents a continuation of Boston Scientific's role as a critical supplier of advanced medical devices to federal healthcare agencies. This non-set-aside award reflects...
- SPE2DE21D7020Indefinite Delivery Contract
- SPE2DE21D7020-SPE2D626F1634Delivery Order
Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, was awarded a $5,447.25 delivery order by the Defense Health Agency's Medical Supply Chain for an Enroute Transcarotid Neuroprotection System with a completion date of October 21, 2025. This fixed-price contract with economic price adjustment features no set-aside designation, allowing Boston Scientific to compete openly in the federal marketplace. The award reflects the company's established position as a prime contractor supplying advanced cardiovascular and interventional medical devices to federal healthcare agencies, particularly the Department of Defense and Department of Veterans Affairs. This delivery order is issued under Boston Scientific's broader relationship with the Defense Health Agency and leverages the company's extensive portfolio of specialized medical devices and solutions. The transcarotid neuroprotection system represents a critical component of Boston Scientific's cardiovascular intervention capabilities, which includes stents, catheters, drug-coated balloons, and diagnostic equipment. The work will be performed at the company's Marlborough, Massachusetts facility, maintaining Boston Scientific's operational presence in its headquarters location while supporting the federal government's medical supply chain requirements for advanced cardiac intervention technologies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.4k | 10/14/25 |